Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 3 |
2016 | 2 |
2017 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.
PLoS One. 2015 Mar 17;10(3):e0119683. doi: 10.1371/journal.pone.0119683. eCollection 2015.
PLoS One. 2015.
PMID: 25781999
Free PMC article.
Review.
Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland.
Aaltonen KJ, Joensuu JT, Pirilä L, Kauppi M, Uutela T, Varjolahti-Lehtinen T, Yli-Kerttula T, Isomäki P, Nordström D, Sokka T.
Aaltonen KJ, et al. Among authors: joensuu jt.
Scand J Rheumatol. 2017 Sep;46(5):359-363. doi: 10.1080/03009742.2016.1234641. Epub 2016 Dec 8.
Scand J Rheumatol. 2017.
PMID: 27931158
Item in Clipboard
Effectiveness and Drug Survival of TNF Inhibitors in the Treatment of Ankylosing Spondylitis: A Prospective Cohort Study.
Heinonen AV, Aaltonen KJ, Joensuu JT, Lähteenmäki JP, Pertovaara MI, Romu MK, Hirvonen HE, Similä AK, Blom ML, Nordström DC.
Heinonen AV, et al. Among authors: joensuu jt.
J Rheumatol. 2015 Dec;42(12):2339-46. doi: 10.3899/jrheum.150389. Epub 2015 Oct 15.
J Rheumatol. 2015.
PMID: 26472421
Item in Clipboard
Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study.
Joensuu JT, Aaltonen KJ, Aronen P, Sokka T, Puolakka K, Tuompo R, Korpela M, Vasala M, Ilva K, Nordström D, Blom M.
Joensuu JT, et al.
Rheumatology (Oxford). 2016 Oct;55(10):1803-11. doi: 10.1093/rheumatology/kew264. Epub 2016 Jun 27.
Rheumatology (Oxford). 2016.
PMID: 27354689
Item in Clipboard
Rates of serious infections and malignancies among patients with rheumatoid arthritis receiving either tumor necrosis factor inhibitor or rituximab therapy.
Aaltonen KJ, Joensuu JT, Virkki L, Sokka T, Aronen P, Relas H, Valleala H, Rantalaiho V, Pirilä L, Puolakka K, Uusitalo T, Blom M, Konttinen YT, Nordström D.
Aaltonen KJ, et al. Among authors: joensuu jt.
J Rheumatol. 2015 Mar;42(3):372-8. doi: 10.3899/jrheum.140853. Epub 2015 Jan 15.
J Rheumatol. 2015.
PMID: 25593230
Item in Clipboard
Cite
Cite